A groundbreaking study reported by The Daily Mail reveals a potential new treatment for migraine sufferers using a cheap, readily available drug. Researchers have found that Rimegepant, a medication originally used to treat acute migraine attacks, can also be effective in preventing them. This discovery offers hope for millions of people worldwide who suffer from chronic migraines, which significantly impact quality of life. The study shows that taking Rimegepant every other day could reduce the frequency of migraine attacks, offering an alternative to more expensive treatments currently available. Patients who participated in the trial experienced fewer headaches and reported improved daily functioning and well-being. The drug's affordability and accessibility make it a promising option for wider use, particularly for those who may not have had success with other preventative medications.